Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Type Strain
no
Genotype
biA1 veA1
RefYu JH, Leonard TJ. Sterigmatocystin biosynthesis in Aspergillus nidulans requires a novel type I polyketide synthase. J. Bacteriol. 177: 4792-4800, 1995. PubMed: 7642507
Preceptrol®
no
Genome Sequenced Strain
Yes
Ploidy
haploid
Comments
Virulence same as prototrophic strain.
Mycotic virulence and its genetic control
Genome sequencing strain (University of Oklahoma, USA).
Medium
ATCC® Medium 25: Yeast extract-glucose medium
ATCC® Medium 25: Yeast extract-glucose medium
ATCC® Medium 627: Aspergillus medium
Growth Conditions
Temperature: 37.0°C
Sequenced Data
No DNA sequencing was performed in house on this product.
Barratt RW, et al. Wild-type and mutant stocks of Aspergillus nidulans. Genetics 52: 233-246, 1965. PubMed: 5857598
Purnell DM, Martin GM. Aspergillus nidulans: association of certain alkaline phosphatase mutations with decreased virulence for mice. J. Infect. Dis. 123: 305-306, 1971. PubMed: 5111886
Yu JH, Leonard TJ. Sterigmatocystin biosynthesis in Aspergillus nidulans requires a novel type I polyketide synthase. J. Bacteriol. 177: 4792-4800, 1995. PubMed: 7642507
Yu JH, Leonard TJ. Sterigmatocystin biosynthesis in Aspergillus nidulans requires a novel type I polyketide synthase. J. Bacteriol. 177: 4792-4800, 1995. PubMed: 7642507